PetMed Express
Market Cap
US$665.3m
Last Updated
2021/04/11 22:19 UTC
Data Sources
Company Financials +
Executive Summary
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. More Details
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet with solid track record and pays a dividend.
Similar Companies
Share Price & News
How has PetMed Express's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PETS is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 15% a week.
Volatility Over Time: PETS's weekly volatility has increased from 10% to 15% over the past year.
Market Performance
7 Day Return
-2.6%
PETS
3.2%
US Online Retail
2.1%
US Market
1 Year Return
13.0%
PETS
60.3%
US Online Retail
56.3%
US Market
Return vs Industry: PETS underperformed the US Online Retail industry which returned 60.3% over the past year.
Return vs Market: PETS underperformed the US Market which returned 56.3% over the past year.
Shareholder returns
| PETS | Industry | Market | |
|---|---|---|---|
| 7 Day | -2.6% | 3.2% | 2.1% |
| 30 Day | -7.4% | 0.5% | 2.4% |
| 90 Day | -2.2% | -0.5% | 6.1% |
| 1 Year | 16.9%13.0% | 60.5%60.3% | 59.1%56.3% |
| 3 Year | -2.3%-13.4% | 94.4%94.2% | 65.7%55.1% |
| 5 Year | 122.0%85.5% | 304.1%303.5% | 122.3%97.6% |
Long-Term Price Volatility Vs. Market
How volatile is PetMed Express's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall St
PetMed Express, Inc.'s (NASDAQ:PETS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?2 weeks ago | Simply Wall St
Is PetMed Express, Inc. (NASDAQ:PETS) An Attractive Dividend Stock?1 month ago | Simply Wall St
Estimating The Intrinsic Value Of PetMed Express, Inc. (NASDAQ:PETS)Valuation
Is PetMed Express undervalued compared to its fair value and its price relative to the market?
12.4%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PETS ($33.11) is trading below our estimate of fair value ($37.84)
Significantly Below Fair Value: PETS is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: PETS is good value based on its PE Ratio (21.5x) compared to the US Online Retail industry average (34.6x).
PE vs Market: PETS is good value based on its PE Ratio (21.5x) compared to the US market (22.3x).
Price to Earnings Growth Ratio
PEG Ratio: PETS is poor value based on its PEG Ratio (1.9x)
Price to Book Ratio
PB vs Industry: PETS is good value based on its PB Ratio (4.8x) compared to the US Online Retail industry average (6.1x).
Future Growth
How is PetMed Express forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
11.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PETS's forecast earnings growth (11.6% per year) is above the savings rate (2%).
Earnings vs Market: PETS's earnings (11.6% per year) are forecast to grow slower than the US market (18.6% per year).
High Growth Earnings: PETS's earnings are forecast to grow, but not significantly.
Revenue vs Market: PETS's revenue (3.4% per year) is forecast to grow slower than the US market (9.9% per year).
High Growth Revenue: PETS's revenue (3.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PETS's Return on Equity is forecast to be high in 3 years time (23.6%)
Past Performance
How has PetMed Express performed over the past 5 years?
6.5%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PETS has high quality earnings.
Growing Profit Margin: PETS's current net profit margins (9.9%) are higher than last year (9.3%).
Past Earnings Growth Analysis
Earnings Trend: PETS's earnings have grown by 6.5% per year over the past 5 years.
Accelerating Growth: PETS's earnings growth over the past year (20.9%) exceeds its 5-year average (6.5% per year).
Earnings vs Industry: PETS earnings growth over the past year (20.9%) underperformed the Online Retail industry 66.3%.
Return on Equity
High ROE: PETS's Return on Equity (22.1%) is considered high.
Financial Health
How is PetMed Express's financial position?
Financial Position Analysis
Short Term Liabilities: PETS's short term assets ($141.0M) exceed its short term liabilities ($26.9M).
Long Term Liabilities: PETS's short term assets ($141.0M) exceed its long term liabilities ($1.3M).
Debt to Equity History and Analysis
Debt Level: PETS is debt free.
Reducing Debt: PETS has not had any debt for past 5 years.
Debt Coverage: PETS has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PETS has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is PetMed Express's current dividend yield, its reliability and sustainability?
3.38%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: PETS's dividend (3.38%) is higher than the bottom 25% of dividend payers in the US market (1.26%).
High Dividend: PETS's dividend (3.38%) is low compared to the top 25% of dividend payers in the US market (3.5%).
Stability and Growth of Payments
Stable Dividend: PETS's dividends per share have been stable in the past 10 years.
Growing Dividend: PETS's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (72.2%), PETS's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: PETS's dividends in 3 years are forecast to be covered by earnings (78% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
19.9yrs
Average management tenure
CEO
Menderes Akdag (59 yo)
20.08yrs
Tenure
US$1,303,460
Compensation
Mr. Menderes Akdag has been the Chief Executive Officer of PetMed Express, Inc. since March 16, 2001 and has been its President since August 2005. Mr. Akdag has a breadth of experience in the areas of dire...
CEO Compensation Analysis
Compensation vs Market: Menderes's total compensation ($USD1.30M) is below average for companies of similar size in the US market ($USD2.16M).
Compensation vs Earnings: Menderes's compensation has increased by more than 20% in the past year.
Leadership Team
Experienced Management: PETS's management team is seasoned and experienced (19.9 years average tenure).
Board Members
Experienced Board: PETS's board of directors are seasoned and experienced ( 17.7 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: PETS insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
PetMed Express, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: PetMed Express, Inc.
- Ticker: PETS
- Exchange: NasdaqGS
- Founded: 1996
- Industry: Internet and Direct Marketing Retail
- Sector: Retail
- Market Cap: US$665.316m
- Shares outstanding: 20.09m
- Website: https://www.1800petmeds.com
Number of Employees
Location
- PetMed Express, Inc.
- 420 South Congress Avenue
- Delray Beach
- Florida
- 33445
- United States
Listings
Biography
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/04/11 22:19 |
| End of Day Share Price | 2021/04/09 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.